Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on RDEA594. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103524440A details a safer, thiophosgene-free route for Lesinurad intermediates, offering cost reduction and scalable manufacturing for gout therapeutics.